Cationic amphipathic peptides KT2 and RT2 are taken up into bacterial cells and kill planktonic and biofilm bacteria

Biochimica Et Biophysica Acta
Thitiporn AnunthawanSompong Klaynongsruang

Abstract

We investigated the mechanisms of two tryptophan-rich antibacterial peptides (KT2 and RT2) obtained in a previous optimization screen for increased killing of both Gram-negative and Gram-positive bacteria pathogens. At their minimal inhibitory concentrations (MICs), these peptides completely killed cells of multidrug-resistant, enterohemorrhagic pathogen Escherichia coli O157:H7 within 1-5 min. In addition, both peptides exhibited anti-biofilm activity at sub-MIC levels. Indeed, these peptides prevented biofilm formation and triggered killing of cells in mature E. coli O157:H7 biofilms at 1 μM. Both peptides bound to bacterial surface LPS as assessed using the dansyl-polymyxin displacement assay, and were able to interact with the lipids of liposomes as determined by observing a tryptophan blue shift. Interestingly, even though these peptides were highly antimicrobial, they did not induce pore formation or aggregates in bacterial cell membranes. Instead these peptides readily penetrated into bacterial cells as determined by confocal microscopy of labeled peptides. DNA binding assays indicated that both peptides bound to DNA with higher affinity than the positive control peptide buforin II. We propose that cationic peptides KT2 ...Continue Reading

References

Oct 1, 1976·Immunochemistry·D C Morrison, D M Jacobs
Nov 7, 1998·Biochimica Et Biophysica Acta·K Matsuzaki
Feb 9, 2000·Trends in Pharmacological Sciences·S R Schwarze, S F Dowdy
Feb 26, 2000·Trends in Pharmacological Sciences·M LindgrenU Langel
Jun 17, 2000·Trends in Cell Biology·S R SchwarzeS F Dowdy
Nov 30, 2000·The Journal of Peptide Research : Official Journal of the American Peptide Society·D J MitchellJ B Rothbard
Jul 27, 2001·The Journal of Biological Chemistry·L ZhangR E Hancock
Feb 19, 2002·Current Opinion in Biotechnology·Jehangir S Wadia, Steven F Dowdy
Nov 21, 2002·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·David J SchibliRichard M Epand
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Jon-Paul S PowersRobert E W Hancock
Nov 28, 2007·Expert Review of Anti-infective Therapy·John D F Hale, Robert E W Hancock
Jul 20, 2010·Biochimica Et Biophysica Acta·Yun LanA James Mason
Mar 10, 2012·Biochimica Et Biophysica Acta·Astrid WalrantIsabel D Alves
May 15, 2013·FEBS Letters·Chérine Bechara, Sandrine Sagan
Jul 9, 2013·Bioorganic & Medicinal Chemistry Letters·Thitiporn AnunthawanSompong Thammasirirak
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Michaela WenzelJulia Elisabeth Bandow

❮ Previous
Next ❯

Citations

Oct 19, 2016·Current Opinion in Microbiology·Daniel PletzerRobert Ew Hancock
Jan 27, 2016·Journal of Applied Microbiology·G SharmaR Gabrani
Nov 23, 2016·Journal of Dental Research·B Bechinger, S-U Gorr
May 26, 2017·The Journal of Physical Chemistry. B·Peter W AkersDuncan J McGillivray
Apr 14, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lisa LombardiArianna Tavanti
May 19, 2018·Biomolecules·Athina AndreaHåvard Jenssen
Jul 20, 2016·Antimicrobial Agents and Chemotherapy·Lei WeiDonald E Elmore
Aug 31, 2019·Drugs·Claudia Vuotto, Gianfranco Donelli
May 3, 2019·BMC Infectious Diseases·Urszula WnorowskaRobert Bucki
Jan 13, 2018·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hamed MemarianiKamran Pooshang Bagheri
Jul 27, 2017·Current Microbiology·Sandra Folarin Oloketuyi, Fazlurrahman Khan
Jul 2, 2019·Current Pharmaceutical Biotechnology·Yara Al TallKarem H Alzoubi
Feb 28, 2016·Applied Microbiology and Biotechnology·Lifen ZongJianhua Wang
Apr 13, 2018·Frontiers in Pharmacology·Anja PfalzgraffGünther Weindl
Apr 29, 2020·Biomolecules·Angela Di SommaAngela Duilio
Jun 2, 2020·Frontiers in Pharmacology·Mohasana AfrozShaikh Jamal Uddin
Dec 31, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rui ZhangGuoqiu Wu
Jan 21, 2021·International Journal of Molecular Sciences·Abid Ali KhanHans-Peter Deigner
Apr 30, 2021·Molecular Biotechnology·Fatemeh HemmatiPourya Gholizadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.